Massachusetts Proposes Installment Plan to Cover Cost of Gene Therapy for Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) is a genetic condition which affects between 10,000 and 25,000 in the United States. While rare, it is currently the leading genetic cause of infant mortality. But,…